Clinical Trial Update: A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with lamivudine and dolutegravir in HIV-1 infected patients virologically suppressed on triple ART; the ANRS 167 La…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Tivicay (dolutegravir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED